Multiple myeloma should be diagnosed by urine tests and serum assays
Serum free light chain assays not total light chain assays are the standard of care to assess Monoclonal Gammopathies - ScienceDirect
PDF] Serum free light chain ratio, total kappa/lambda ratio, and immunofixation results are not prognostic factors after stem cell transplantation for newly diagnosed multiple myeloma. | Semantic Scholar
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
For Myeloma Diagnosis, Urine Tests May Be Better Than Serum, Study Finds
Serum free light chain analysis - Davids - 2010 - American Journal of Hematology - Wiley Online Library
What is KAPPA / LAMBDA LIGHT CHAINS FREE URINE Test ?
N Latex FLC kappa & lambda Assays - Siemens Healthineers
Light Chain Deposition Disease | UNC Kidney Center
Different roles of urinary light chains and serum light chains as potential biomarkers for monitoring disease activity in systemic lupus erythematosus [PeerJ]
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
SDS-PAGE gel analysis of purified urine light chains kappa and... | Download Scientific Diagram
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
Immunofixation - an overview | ScienceDirect Topics
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
The 24-Hour Urine Collection Kit - HealthTree for Myeloma
Table 2 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma | Haematologica
Case 966-- Clinical Chemistry Case
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE